Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-20 | Mr. McInerney joined Riverbank Capital who specializes in financing for the biotech and specialty pharmaceutical industry as a Partner. From 1992 to March 2007, Mr. McInerney was a Managing Director of Paramount BioCapital, Inc. |
| 2010-05-14 | Timothy McInerney has been a director of the Company since its September 2005 acquisition of ZIOPHARM, Inc. and previously served as a Director of ZIOPHARM, Inc. since July 2005. In June of 2007, Mr. McInerney joined Riverbank Capital who specializes in financing for the biotech and specialty pharmaceutical industry as a Partner. |
| 2011-05-02 | Timothy McInerney has been a director of the Company since its September 2005 acquisition of ZIOPHARM, Inc. and previously served as a Director of ZIOPHARM, Inc. since July 2005. In June of 2007, Mr. McInerney joined Riverbank Capital who specializes in financing for the biotech and specialty pharmaceutical industry as a Partner. |
| 2012-04-30 | He received his B.S. in pharmacy from St. John’s University at New York. |
| 2013-04-29 | He received his B.S. in pharmacy from St. John’s University at New York. |
| 2014-04-30 | Mr. McInerney was a Managing Director of Paramount BioCapital and a research analyst focusing on the biotechnology industry. |
| Filing Date | Source Excerpt |
|---|---|
| 2004-07-28 | Timothy McInerney has been a director of the Company since July 2004. Since 1992, Mr. McInerney has been a Managing Director of Paramount BioCapital, Inc. where he oversees the overall distribution of Paramount's private equity product. Prior to 1992, Mr. McInerney was a research analyst focusing on the biotechnology industry at Ladenburg, Thalman & Co. Prior to that, Mr. McInerney held equity sales positions at Bear, Stearns & Co. and Shearson Lehman Brothers, Inc. Mr. McInerney also has worked in sales and marketing for Bristol-Myers Squibb. He received his B.S. in pharmacy from St. John's University at New York. He also completed a post-graduate residency at the New York University Medical Center in drug information systems. |
| 2005-10-21 | Timothy McInerney has been a director of the Company since July 2004. Since 1992, Mr. McInerney has been a Managing Director of Paramount BioCapital, Inc. where he oversees the overall distribution of Paramount’s private equity product. Prior to 1992, Mr. McInerney was a research analyst focusing on the biotechnology industry at Ladenburg, Thalman & Co. Prior to that, Mr. McInerney held equity sales positions at Bear, Stearns & Co. and Shearson Lehman Brothers, Inc. Mr. McInerney also has worked in sales and marketing for Bristol-Myers Squibb. He received his B.S. in pharmacy from St. John’s University at New York. |
| 2006-11-17 | Timothy McInerney has been a director of Manhattan since July 2004. Since 1992, Mr. McInerney has been a Managing Director of Paramount BioCapital, Inc. where he oversees the overall distribution of Paramount’s private equity product. Prior to 1992, Mr. McInerney was a research analyst focusing on the biotechnology industry at Ladenburg, Thalman & Co. Prior to that, Mr. McInerney held equity sales positions at Bear, Stearns & Co. and Shearson Lehman Brothers, Inc. Mr. McInerney also has worked in sales and marketing for Bristol-Myers Squibb. He received his B.S. in pharmacy from St. John’s University at New York. He also completed a post-graduate residency at the New York University Medical Center in drug information systems. |
| 2007-04-30 | Timothy McInerney has been a director of Manhattan since July 2004. ... The Board of Directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership for each of the Board committees: Audit Committee Messrs. Herskowitz, Hoenlein and Steinhart (Chair) Compensation Committee Messrs. Herskowitz, Hoenlein, Steinhart and Dr. Weiser Nominating and Governance Committee Messrs. Herskowitz, Hoenlein and Steinhart ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2006: Timothy McInerney Fees Earned or Paid in Cash $3,500 Option Awards $44,550 All Other Compensation $0 Total $48,050 |
| 2008-05-12 | Timothy McInerney has been a director of Manhattan since July 2004. ... Audit Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... Compensation Committee members: Messrs. Herskowitz, Hoenlein, Steinhart and Weiser (Chair). ... Nominating and Governance Committee members: Messrs. Herskowitz, Hoenlein and Steinhart (Chair). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2007: Timothy McInerney total compensation $31,948. |
| 2009-10-29 | Timothy McInerney has been a director of Manhattan since July 2004. Mr. McInerney serves as a partner at Riverbank Capital Securities, Inc., a position he has held since June 2007. ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2008: Timothy McInerney (4) $5,500 $14,767 - $20,267 ... Compensation Committee: Messrs. McInerney, Steinhart and Dr. Weiser (Chair) |
| 2011-03-22 | Timothy McInerney has been a director of Manhattan since July 2004. ... Compensation Committee members: Messrs. McInerney, Steinhart and Herskowitz (Chair). ... The following table shows the compensation earned by each of our non-employee directors for the year ended December 31, 2008: Timothy McInerney $32,855 total compensation. |
Data sourced from SEC filings. Last updated: 2026-02-03